Related Experiment Video
Updated: Oct 15, 2025

08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.3K
How glaucoma care changed for the better after the pandemic
1Department of Ophthalmology, Icahn School of Medicine at Mount Sinai and New York Eye and Ear Infirmary of Mount Sinai, New York, New York USA.
Current Opinion in Ophthalmology
|October 26, 2021
Summary
The COVID-19 pandemic accelerated innovations in glaucoma care, including enhanced infection control and hybrid virtual/in-person models. Many of these changes in glaucoma management are expected to continue post-pandemic.
Area of Science:
- Ophthalmology
- Public Health
- Health Services Research
Background:
- The coronavirus disease 19 (COVID-19) pandemic necessitated rapid adaptations in healthcare delivery.
- Glaucoma care, requiring regular monitoring and patient interaction, faced significant disruption.
- The pandemic highlighted the need for resilient and adaptable models of glaucoma management.
Purpose of the Study:
- To review advancements in glaucoma care delivery prompted by the COVID-19 pandemic.
- To identify which pandemic-induced changes are likely to persist in routine practice.
- To assess the impact of these changes on the efficiency and accessibility of glaucoma care.
Main Methods:
- A literature review of publications from 2020-2021 focusing on glaucoma care during the pandemic.
- Analysis of reported changes in infection control, operational workflows, and patient care models.
- Synthesis of findings on the sustainability of implemented modifications.
Main Results:
- Glaucoma practices implemented enhanced infection control measures to reduce severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission.
- Operational adjustments resulted in more efficient glaucoma care delivery.
- A hybrid model combining technician-led diagnostics with virtual specialist consultations emerged as a valuable supplement to traditional care.
Conclusions:
- Glaucoma care has adapted to a "new normal" driven by the pandemic.
- Innovations have improved glaucoma care, but barriers to widespread teleglaucoma implementation remain.
- The long-term impact of the pandemic on glaucoma practice patterns is yet to be fully determined.
Related Concept Videos
Open Angle Glaucoma: Treatment
750
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
750
Angle Closure Glaucoma: Treatment
888
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
888
Glaucoma: Overview
964
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
964

